Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Calypso Guided High Precision Stereotactic Ablative Radiosurgery for Lung Tumors Using Real-Time Tumor Tracking & Respiratory Gating: A Seamless Phase I/II Prospective Clinical Trial

NCT03322072 is registered in ClinicalTrials.gov with CancerCare Manitoba as lead sponsor.

NCT NCT03322072
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03322072 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Calypso Guided High Precision Stereotactic Ablative Radiosurgery for Lung Tumors Using Real-Time Tumor Tracking & Respiratory Gating: A Seamless Phase I/II Prospective Clinical Trial
Lead sponsor
CancerCare Manitoba
Phase
Not applicable
Overall status
Unknown status
Start date
November 23, 2017
Completion date
January 14, 2025
Enrollment
28 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer recurrent, lung cancer stage i, lung cancer stage ii, lung cancer stage iv, lung cancer, nonsmall cell